Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.8.3365

Comparison of Three Dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Low Radiation Exposure of Normal Tissue in Patients with Prostate Cancer  

Cakir, Aydin (Department of Radiation Oncology, Oncology Institute, Istanbul University)
Akgun, Zuleyha (Department of Radiation Oncology, Faculty of Medicine, Bezmialem Vakif University)
Fayda, Merdan (Department of Radiation Oncology, Oncology Institute, Istanbul University)
Agaoglu, Fulya (Department of Radiation Oncology, Oncology Institute, Istanbul University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.8, 2015 , pp. 3365-3370 More about this Journal
Abstract
Radiotherapy has an important role in the treatment of prostate cancer. Three-dimensional conformal radiation therapy (3D-CRT), intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) techniques are all applied for this purpose. However, the risk of secondary radiation-induced bladder cancer is significantly elevated in irradiated patients compared surgery-only or watchful waiting groups. There are also reports of risk of secondary cancer with low doses to normal tissues. This study was designed to compare received volumes of low doses among 3D-CRT, IMRT and VMAT techniques for prostate patients. Ten prostate cancer patients were selected retrospectively for this planning study. Treatment plans were generated using 3D-CRT, IMRT and VMAT techniques. Conformity index (CI), homogenity index (HI), receiving 5 Gy of the volume (V5%), receiving 2 Gy of the volume (V2%), receiving 1 Gy of the volume (V1%) and monitor units (MUs) were compared. This study confirms that VMAT has slightly better CI while thev olume of low doses was higher. VMAT had lower MUs than IMRT. 3D-CRT had the lowest MU, CI and HI. If target coverage and normal tissue sparing are comparable between different treatment techniques, the risk of second malignancy should be a important factor in the selection of treatment.
Keywords
Low dose volumes; secondary cancer; volumetric modulated arc therapy; prostate cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z (2005). Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys, 63, 765-71.   DOI   ScienceOn
2 Bortfeld T and Webb S.(2009). Single Arc IMRT ? Phys Med Biol, 54, 9-20.
3 Brenner DJ, Curtis RE, Hall EJ, et al (2000). Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer, 88, 398-406.   DOI
4 Budäus L, Bolla M, Bossi A, et al (2012). Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature. Eur Urol, 61, 112-27 .   DOI
5 Cahlon O, Zelefsky MJ, Shippy A, et al (2008). Ultra-high dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys, 71, 330-7.   DOI
6 Cao D, Holmes TW, Afghan MK, et al (2007). Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys, 69, 240-50.   DOI   ScienceOn
7 Cozzi L, Dinshaw KA, Shrivastava SK, et al (2008). A treatment plan-ning study comparing volumetric arc modulation with Rapi-dArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol, 89, 180-91.   DOI
8 Ding X, Dionisi F, Tang S, et al (2014). A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulatedscanning proton therapy (PT). Med Dosim, 39, 139-45.   DOI
9 Followill DS, Stovall MS, Kry SF, Ibbott GS (2003). Neutron source strength measurements for Varian, Siemens, Elekta and General Electric linear aacelerators. J Appl Clin Med Phys, 4, 189-94.   DOI
10 Hall EJ, Wuu C (2003). Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys, 56, 83-88.   DOI
11 Hall EJ (2006). Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Ooncol Biol Phys, 65, 1-7.   DOI
12 Kendal, WS, Nicholas, G (2007) A populationbased analysis of second primary cancers after irradiation for rectal cancer. Am J Clin Oncol, 30, 333-9.   DOI
13 Kry SF, Salehpour M, Followill DS, et al (2005). The calculated risk of fatal secondary malignancies from intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys, 62, 1195-1203.   DOI
14 Kutcher GJ, Burman C (1989). Calculation of complication probability factors for non-uniform normal tissue radiation:The effective volume method. Int J Radiat Oncol Biol Phys, 16, 1623-30.   DOI
15 Luxton G, Hancock SL, Boyer AL(2004). Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys, 59, 267-84.   DOI
16 Murray L, Henry A, Hoskin P, et al (2013). Second primary cancers after radiation for prostate cancer:a review of data from planning studies. Radiation Oncology, 8, 172 .   DOI
17 National council on radiation protection and measurements. limitation of exposure to ionizing radiation. NCRP report 116. bethesda (md): national council on radiation protection and measurements; 1993.
18 Ottolenghi A, Smyth V, Trott KR (2011). The risk to healthy tissues from the use of existing and emerging techniques for radiation therapy. Radiat Prot Dosim, 143, 533-35 .   DOI
19 Nieder AM, Porter MP, Soloway MS (2008) Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol, 180, 2005-2010.   DOI
20 Otto K (2008).Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys, 35, 310-7.   DOI
21 Palma D, Vollans E, James K, et al (2008). Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 72, 996-1001   DOI
22 Pasquier D, Cavillon F, Lacornerie T, et al (2013). A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Int J Radiat Oncol Biol Phys, 85, 549-54.   DOI
23 Preston D, Shimizu Y, Pierce D, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13:solid cancer and non cancer mortality, 1950-1977. Radiat Res, 160, 381-407.   DOI
24 Rechner LA, Howell RM, Zhang R, et al (2012). Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol, 57, 7117-32 .   DOI
25 Romanenko A, Morimura K, Wanibuchi H, et al (2003). Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation. Cancer Sci, 94, 328-333.   DOI
26 Ruben JD, Davis S, Evans C, et al (2008). The effect of intensitymodulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys, 70, 1530-6.   DOI
27 Swamy ST, Radha CA, Kathirvel M, Arun G, Subramanian S (2014). Feasibility study of deep inspiration breath-hold based volumetric modulated arc therapy for locally advanced left sided breast cancer patients. Asian Pac J Cancer Prev, 15, 9033-8.   DOI
28 Shaffer R, Morris WJ, Moiseenko V, Welsh M, et al (2009). Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study. Clin Oncol, 21, 401-7.   DOI
29 Shepard DM, Cao D, Afghan MK, et al (2007). An arc-sequencing algorithm for intensity modulated arc therapy. Med Phys, 34, 464-470.   DOI
30 Sountoulides P, Koletsas N, Kikidakis D, et al (2010). Secondary malignancies following radiotherapy for prostate cancer. Ther Adv Urol, 2, 119-125 .   DOI
31 Tsai CL, Wu JK, Chao HL, Tsai YC, et al (2011). Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Medical Dosimetry, 36, 264-271.   DOI
32 Wang B, Xu XG (2008). Measurements of non-target organ doses using mosfet dosemeters for selected IMRT and 3D CRT radiation treatment procedures. Radiat Prot Dosim, 128, 336-42 .
33 Wolff JM, Mason M (2012). Drivers for change in the management of prostate cancer-guidelines and new treatment techniques. BJU Int, 109, 33-41.   DOI
34 Wu VW, Kwong DL, Sham JS (2004) Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol, 71, 201-6.   DOI
35 Xu XG, Bednarz B and Paganetti H(2008). A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol, 53, 193-241.   DOI
36 Zelefsky MJ, Pei X, Teslova T, et al (2012). Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. BJU Int, 110, 1696-701.   DOI
37 Yu CX, Li XA, Ma L, et al (2002). Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys, 53, 453-63.   DOI
38 Zelefsky MJ, Fuks Z, Happersett L, et al (2000). Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol, 55, 241-9.   DOI
39 Zelefsky MJ, Levin EJ, Hunt M, et al. (2008). Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys, 70, 1124-9.   DOI   ScienceOn